For the first time, clumps of human cells called organoids were fully integrated with the brains of rats—and influenced their ...

While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise ...

CytoMed remains committed to advancing its pipeline responsibly and to communicating accurate, timely information through official Company disclosures. The Company reserves the right to take ...

While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive ...

CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing ...

UCLA Health researchers have created a comprehensive map showing how eight different genetic mutations associated with autism spectrum disorder affect early brain development, providing new insights ...

Harvard researchers have developed a method to grow specialized neurons, offering hope for better treatments for ALS and ...

Funding for fetal tissue research had already been declining, according to NIH data. In the 2024 fiscal year, the agency spent $53 million on 77 projects that used fetal tissue. That was down from ...

Explore the groundbreaking study on mini-stomach organoids that replicate human stomach regions for advanced research.

A new study published in Nature in the paper, “Developmental convergence and divergence in human stem cell models of autism,” provides new insights by demonstrating that while different mutations ...

A string of clinical and regulatory milestones in the December quarter highlighted growing momentum for ASX health stocks ...

TRPML1 is a promising target1 for Parkinson’s disease treatments and identifying translational biomarkers will help confirm target engagement ...